Literature DB >> 12057117

Primary hyperparathyroidism.

R Udelsman1.   

Abstract

Treatment of primary hyperparathyroidism depends on a clear diagnosis based on biochemical confirmation. Most patients have an elevated serum total or ionized calcium level in association with an elevated or inappropriate serum intact parathyroid hormone level. The serum calcium level can be lowered by hydration and by a variety of pharmacologic agents. However, none of these agents is effective in the long-term management of primary hyperparathyroidism. The extraordinarily high success rate of surgery, combined with its low morbidity and the ever-increasing acceptance of minimally invasive techniques, makes surgical resection the recommended treatment for virtually all patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12057117     DOI: 10.1007/s11864-001-0030-8

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  20 in total

1.  Treatment of primary hyperparathyroidism.

Authors:  R D Utiger
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

2.  Concise parathyroidectomy: the impact of preoperative SPECT 99mTc sestamibi scanning and intraoperative quick parathormone assay.

Authors:  S E Carty; J Worsey; M A Virji; M L Brown; C G Watson
Journal:  Surgery       Date:  1997-12       Impact factor: 3.982

3.  Parathyroid imaging: the myth and the reality.

Authors:  R Udelsman
Journal:  Radiology       Date:  1996-11       Impact factor: 11.105

4.  Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism.

Authors:  J L Pasieka; L L Parsons
Journal:  World J Surg       Date:  1998-06       Impact factor: 3.352

5.  One hundred consecutive minimally invasive parathyroid explorations.

Authors:  R Udelsman; P I Donovan; L J Sokoll
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

6.  Assessment of patient outcomes after operation for primary hyperparathyroidism.

Authors:  R E Burney; K R Jones; J W Coon; D K Blewitt; A M Herm
Journal:  Surgery       Date:  1996-12       Impact factor: 3.982

7.  Parathyroidectomy in Maryland: effects of an endocrine center.

Authors:  H Chen; M A Zeiger; T A Gordon; R Udelsman
Journal:  Surgery       Date:  1996-12       Impact factor: 3.982

Review 8.  How to recognize and treat parathyroid carcinoma.

Authors:  Y Fujimoto; T Obara
Journal:  Surg Clin North Am       Date:  1987-04       Impact factor: 2.741

9.  Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture.

Authors:  S Ljunghall; P Hellman; J Rastad; G Akerström
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 10.  NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement.

Authors: 
Journal:  Ann Intern Med       Date:  1991-04-01       Impact factor: 25.391

View more
  3 in total

1.  [Central giant cell granuloma and osteitis fibrosa cystica of hyperparathyroidism. A challenge in differential diagnosis of patients with osteolytic jawbone lesions and a history of cancer].

Authors:  M Thorwarth; S Rupprecht; A Schlegel; D Neureiter; P Kessler
Journal:  Mund Kiefer Gesichtschir       Date:  2004-07-29

2.  Jaw tumor in primary hyperparathyroidism is not always a brown tumor.

Authors:  Laila Ennazk; Ghizlane El Mghari; Nawal El Ansari
Journal:  Clin Cases Miner Bone Metab       Date:  2016-05-11

3.  The Current Role of Parathyroid Fine-Needle Biopsy (P-FNAB) with iPTH-Washout Concentration (iPTH-WC) in Primary Hyperparathyroidism: A Single Center Experience and Literature Review.

Authors:  Łukasz Obołończyk; Izabela Karwacka; Piotr Wiśniewski; Krzysztof Sworczak; Tomasz Osęka
Journal:  Biomedicines       Date:  2022-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.